A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma
- 14 April 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (4) , 681-684
- https://doi.org/10.1016/0277-5379(88)90299-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot studyCancer, 1985
- Chemotherapy for multiple myelomaCancer, 1984
- Timed sequential chemotherapy of cytoxan-refractory multiple myeloma with cytoxan and adriamycin based on induced tumor proliferationBlood, 1981
- TIMED SEQUENTIAL CHEMOTHERAPY OF CYTOXAN-REFRACTORY MULTIPLE-MYELOMA WITH CYTOXAN AND ADRIAMYCIN BASED ON INDUCED TUMOR PROLIFERATION1981
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980
- Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline DrugsPublished by S. Karger AG ,1977
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- MULTIPLE-MYELOMA - QUANTITATIVE STAGING AND ASSESSMENT OF RESPONSE WITH A PROGRAMMABLE POCKET CALCULATOR1977